Surgeons can draw fibrin, a protein involved in blood clotting, from peripheral blood (PB) or bone marrow aspirate (BMA), and implant a fibrin blood clot into the injured area to help with healing.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus, causes coronavirus disease 2019 (COVID-19), which is a multisystem disease affecting the respiratory tract. Data ...

A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory ...

The discovery of SERPINB3 opens a new line of research into why some blood clots are more resistant to stroke therapies.

PHILADELPHIA - Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers -- a blood clot -- that stems the loss of blood at an injury ...

The blood protein fibrin plays a key role in stopping bleeding, but in certain circumstance it can also contribute to disease. Therein lies the challenge for developing a fibrin-targeting drug.

The top panel, designed with BioRender.com, illustrates the process of clot formation and lysis, beginning with platelet aggregation and activation of the coagulation cascade, followed by the ...

Understanding the physics of clot contraction could potentially lead to new ways to treat bleeding problems and clotting problems. Heart attacks and strokes -- the leading causes of death in human ...

One of the hallmarks of COVID-19, the disease caused by SARS-CoV-2, is a multi-organ system process characterized by the formation of blood clots in small vessels. What was most puzzling in the early ...

Researchers analyze bone marrow-derived and peripheral blood-derived fibrin clots showing that the former contains more growth factors. They then show that bone marrow-derived fibrin clots can be used ...